# Acamprosate Calcium

NDC: 50268-028
Generic name: Acamprosate Calcium
Labeler / Manufacturer: AvPAK
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20261026

FDA application: ANDA219904

## Active ingredients

- ACAMPROSATE CALCIUM: 333 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50268-028"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50268-028